Pakistani scientist to receive Friendship Award from China
By
China to confer Friendship Award on Pakistani scientist
Prof Dr M Iqbal Choudhary will be given a medal and roughly more than $15,000 in prize money
Award ceremony is in China in March next year
ISLAMABAD: Pakistani scientist Prof Dr M Iqbal Choudhary will be getting a Friendship Award from China for his outstanding contribution to the economic and social development of Guangxi, an autonomous region in southern China, bordering Vietnam.
The decision was made by the People’s Government of Guangxi Zhuang to honour Dr Choudhary with the 2020 Guangxi Golden Silkball Friendship Award on the recommendation of Guangxi Normal University.
Workshop held for assessment of MDCAT qualifying students
National
December 26, 2020
PESHAWAR: A workshop was organised for standardised assessment of the entrance test qualifying students into the private sector medical colleges of Khyber Pakhtunkhwa.
The event was jointly organised by Peshawar Medical College (PMC), Peshawar Dental College (PDC), Shifa College of Medicine and Tameer-e-Millat University Islamabad, while adhering to the Covid-19 protocols including the safe physical distancing, said a press release.
The participants discussed the standardised assessment of the eligible medical and dental colleges admission test (MDCAT) qualifying students into the private sector medical colleges of KP so that the allocated 20 per cent marks can be judiciously and transparently allocated to the aspiring students while assessing them for a host of relevant soft skills.Prof Dr Hafeez-ur-Rahman, dean, PMC, welcomed the guest resource persons and the participating faculty members f
Cost-effective medicines used for treatment of psychiatric illnesses, neurological disorders and mental sicknesses are no longer available in the market after several pharmaceutical companies have stopped their production. AFP/File
KARACHI: Amid a growing number of Covid-19 cases and serious pressure on hospitals across Pakistan because of them, the country’s health system faces yet another crisis as dozens of cost-effective medicines used for treatment of psychiatric illnesses, neurological disorders and mental sicknesses are no longer available in the market after several pharmaceutical companies have stopped their production either due to lack of business viability or regulatory hiccups, officials and industry sources have said.